Schedules of controlled substances: placement of pregabalin into schedule V. Final rule.
This final rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic acid], including its salts, and all products containing pregabalin into Schedule V of the Controlled Substances Act (CSA). As a result of this rule, the regulatory controls and criminal sanctions of Schedule V will be applicable to the manufacture, distribution, dispensing, importation and exportation of pregabalin and products containing pregabalin.
D000700:Analgesics / Q000145:classification / Q000627:therapeutic use; D003929:Diabetic Neuropathies / Q000628:therapy; D004349:Drug Packaging / Q000331:legislation & jurisprudence; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D006801:Humans; D014481:United States; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000145:classification* / Q000627:therapeutic use
D000700:Analgesics; D005680:gamma-Aminobutyric Acid